MBX (MBX Biosciences Inc) Earnings per share growth in current year

Official company branding of MBX Biosciences Inc (MBX)

MBX Biosciences Inc (MBX) revenues are based on the future sale of innovative peptide therapies for hormonal correction. The EPS trajectory compared to last year serves as a confidence indicator, with the current mark at -44.50. However, early-stage testing and capital shortages create risks. Stability is provided by a strong staff of scientists and the hiring of US compliance experts.

Earnings per share growth in current year: MBX Biosciences, Inc. (MBX) for 09/14/2024 - 11/15/2026

Analytical breakdowns and data insights for company MBX Biosciences, Inc. (MBX)

- market value and analyst target forecast:
- business market valuation indicators:
Basic company analysis:MBX, MBX Corp
Mass-produced product of MBX Biosciences

This indicator measures the annual percentage change in net earnings per share, allowing for an assessment of real capital generation efficiency relative to the previous year. An analysis of year-over-year earnings per share dynamics reveals the financial stability of MBX Biosciences Inc (MBX), where the metric's volatility reflects the costs of developing the peptide platform and the diversification of clinical trials for obesity treatment.

Main competitors

ASND: Net earnings per one share growth for the current year|MDGL (Madrigal Corp) - Earnings growth in current year|Earnings growth in current year Corcept Therapeutics|Earnings growth in current year RYTM|Earnings per share growth in current year AKRO (Akero Therapeutics, Inc.)|Earnings per share growth in current year metsera.com MTSR|MoonLake Corp (MLTX) - Earnings per share growth rate in current year|CRNX - Earnings per share growth in current year|NAMS: Earnings per share growth in current year|SLNO: Earnings growth in current year|FOLD - Expected net earnings per share growth this year|Earnings per share growth in current year 89bio Pharma|Agios Corp (AGIO) - Expected net earnings per share growth this year|Earnings per share growth in current year structuretx.com (GPCR)|Net earnings per share growth this year mimedx.com MDXG|Earnings per share growth in current year Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Earnings per share growth in current year|ALT: Net earnings per share growth this year|AARD - Earnings growth in current year|SGMT: Earnings growth in current year|Earnings per share growth rate in current year BioAge Labs, Inc. (BIOA)|Earnings per share growth in current year Biomea Fusion Inc|Earnings per share growth this year QNCX (Quince Therapeutics)|Net earnings per share growth this year GUTS (Fractyl Health)|Net earnings per one share growth for the current year VTVT|Agape ATP Corporation - Net earnings per share growth this year|Earnings per share increase in current year PLUR|Synlogic Inc. - Earnings growth in current year|LPCN (Lipocine) - Earnings per share growth this year|MTNB (Matinas BioPharma Holdings Inc.) - Net earnings per share growth this year|SPRB (Spruce Biosciences, Inc.) - Earnings per share growth in current year|GLTO (galecto.com) - Earnings growth in current year|Net earnings per share growth this year carmellrx.com (CTCX)|Earnings per share growth in current year Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Earnings per share increase in current year|radiuspharm.com - Net earnings per share growth this year